Funding for this research was provided by:
National Institutes of Health (UM1 HG008898)
Received: 1 May 2021
Accepted: 2 September 2021
First Online: 14 September 2021
: Informed consent was obtained for individual HS1011 under protocol H-29697, which is approved by the Institutional Review Board at Baylor College of Medicine. This protocol provides consent to publish the detailed genomic information contained in this manuscript.
: W.T. has two patents (8,748,091 and 8,394,584) licensed to Oxford Nanopore Technologies. FJS and W.T. have received travel funds to speak at symposia organized by Oxford Nanopore Technologies.